chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sneezing; runny nose; itchy eyes; watery eyes; Cough; wheezy; arm was hot; arm was swollen; skin has a stain from shot; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (sneezing), RHINORRHOEA (runny nose), EYE PRURITUS (itchy eyes), LACRIMATION INCREASED (watery eyes) and COUGH (Cough) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma since an unknown date.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced SNEEZING (sneezing) and RHINORRHOEA (runny nose). an unknown date, the patient experienced EYE PRURITUS (itchy eyes), LACRIMATION INCREASED (watery eyes), COUGH (Cough), WHEEZING (wheezy), SENSITIVE SKIN (arm was hot), PERIPHERAL SWELLING (arm was swollen) and VACCINATION SITE ERYTHEMA (skin has a stain from shot). At the time of the report, SNEEZING (sneezing), RHINORRHOEA (runny nose), EYE PRURITUS (itchy eyes), LACRIMATION INCREASED (watery eyes), COUGH (Cough), WHEEZING (wheezy), SENSITIVE SKIN (arm was hot), PERIPHERAL SWELLING (arm was swollen) and VACCINATION SITE ERYTHEMA (skin has a stain from shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.    Treatment information was not provided.
Noticed rash in right arm on 5-13-22. Wonders if vaccine related, or bug bites. Only uncomfortable if he touches the area. Area feels warm. There is redness that seems bigger than when redness was first noted. Denies fever. Denies itching.   States he has had varicella vaccine in the past, but did not have documentation so proceeded with repeat varicella vaccination. There was no varicella titer checked prior to vaccination.
app one our after receiving 2nd Covid Vaccine, associate began to have chills which progressed to fatigue and body aches over next 3 days and now with both hands edematous and painful.  Referred associate to seek appointment with PCP with next 24 to 48 hours unless associate feels she needs to go to the emergency room.  Denies any other c/o at this time except for fatigue and hand edema with pain.
Pain in the jaw, neck, throat, bilateral lymph pain/swelling, sweating, chills, weakness - neck pain, swelling, lymphadenopathy persist now Taking acetaminophen. At home for now. Also adv warm compresses/drinks for comfort. Adv to FU with HCF trouble breathing or if symptoms persist/worsen.
fatigue; intermittent nausea / nausea; backache; This case was reported by a consumer via call center representative and described the occurrence of fatigue in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included sarcoidosis, covid-19 and asthma.   On 24th August 2022, the patient received the 1st dose of Shingrix. On 25th August 2022, 1 days after receiving Shingrix, the patient experienced fatigue, nausea and back pain. On an unknown date, the outcome of the fatigue, nausea and back pain were recovered/resolved.   It was unknown if the reporter considered the fatigue, nausea and back pain to be related to Shingrix.     Additional Information: GSK Receipt Date: 31-AUG-2022 Reporter's Comment: The patient received the first of two doses of Shingrix vaccine on 24.August 2022 and on 25. August 2022, experienced fatigue, intermittent nausea and backache which have all resolved. The reporter inquiring if these symptoms were side effects of Nucala or Shingrix. The reporter had notified her HCP. Reporter had given consent to follow up with her HCP. Spoke from content for Shingrix package insert. Declined safety statement. Provided medical advice disclaimer and HCP referral.  Provided product education.  Lot numbers and expiration dates were not known for Shingrix. Patient has given consent to follow up with her HCP.  Consented to follow up.
Presented with cough, SOB x10 days; dx covid 10 days PTA; other s/s diarrhea, fever, myalgia, dry mouth; CXR with moderate severe Covid 19 PNA bilat; Labs: D dimer 1.50; CRP 11.84; Ferritin 975; Tx Maxipime, Vit C, Zithromax, vit D3, Doxycycline, lovenox, zinc; at time of d/c-- hypoxia resolved, steroids continued, and antibiotics continued for bil bacterial PNA
enhanced headaches/migraines; enhanced headaches/migraines; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient. A 40-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Aug2021 14:30 (Lot number: FC3183) at the age of 40 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "latex" (unspecified if ongoing), notes: known allergies: latex; "cornmeal" (unspecified if ongoing), notes: known allergies: cornmeal; "walnuts" (unspecified if ongoing), notes: known allergies: walnuts; "almonds" (unspecified if ongoing), notes: known allergies: almonds; "pecans" (unspecified if ongoing), notes: known allergies: pecans; "cats" (unspecified if ongoing), notes: known allergies: cats; "occipital neuralgia" (unspecified if ongoing), notes: other medical history: occipital neuralgia; "chronic migraines" (unspecified if ongoing), notes: other medical history: chronic migraines; "photophobia" (unspecified if ongoing), notes: other medical history: photophobia. The patient concomitant medications were not reported. The following information was reported: MIGRAINE (non-serious), CONDITION AGGRAVATED (non-serious) all with onset 05Aug2021 15:00, outcome recovering, and all described as "enhanced headaches/migraines". The event "enhanced headaches/migraines" and "enhanced headaches/migraines" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of migraine, condition aggravated. Additional information The patient did not receive any other vaccine in four weeks. The patient did not receive any other medications in two weeks. The patient did not have Covid prior vaccination. The patient had not tested for Covid post vaccination. The patient received dose 2, single for Covid -19 immunization product=COVID 19, brand=Pfizer, lot number= FA7485, lot unknown=False, administration date= 26Aug2021 administration time= 02:30 PM, dose number=2 vaccine location=Left arm. Adverse event- 1st dose enhanced headaches/migraines 2nd dose: swelling of face, tightness of jaw, dizziness, hardening of muscles and tissues on arm of injection, chills, bone pain, joint pain, headaches/migraines, diarrhea, nausea, left arm was hot to touch, numbness in left arm.   No follow-up attempts are possible. No further information is expected.
On 10-30-19 reports generalized body aches, slight headache, Slight chills. Denies fever. Called back on 11-1-19 he reports temp 99.2 contact his primary care provider who ordered lab work.
injection site sore for several weeks also, pain and itching on lower back and inside thighs
tested positive for Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for Covid-19) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced COVID-19 (tested positive for Covid-19). At the time of the report, COVID-19 (tested positive for Covid-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sore arm, flu-like symptoms, and hives starting several hours after the injection.  Flu-like symptoms have persisted through the second day.
Patient had high fever spikes of 104 and 103 degrees F. He also had sever muscle pain in the leg of the injection. The injection site was WITHOUT redness, inflammation or heat.
First, the shot hurt when I got the injection.  Most people say they don't even feel it, but I definitely felt the needle  go in and then felt the fluid go in.  By late afternoon, my left arm was very sore .  By  evening, I  couldn't lift my arm at all  due to pain in  that muscle at the top of my shoulder.  I think by that night but perhaps by the next morning I still couldn't lift my arm and the pain had gone into my neck on the left side.  After about 36 hrs, it started getting better but it was extremely sore for at least 4 days.   I still have some residual pain in my left arm and the base of my neck on that side.     About 4 days ago, I noticed  a round bruise about the size of a quarter about 1.5 inches away from where I think the shot was administered.  I am not aware of anything that might have caused it, but Im pretty sure it wasn't where the shot  was administered.  It seems to be growing a bit from when I first noticed it.
Date of Admission: 10/25/2022   Date of Discharge: 10/30/2022   Admission Diagnosis: Acute on chronic congestive heart failure, unspecified heart failure type (CMS/HCC) [I50.9]   Hospital Principal Problem (Discharge Diagnoses): Acute on chronic HFrEF (heart failure with reduced ejection fraction) (CMS/HCC)
Vaccine injection (right arm) 1015 am 3/17/21.  Felt sore arm (right) , dull headache and slight chills and enlarged lymph on right side neck below ear ~7pm.  Following day 10/18 had dull headache and sore arm but minor significance.  Friday 10/19, slight sore arm, no headache. Around 7pm felt sore right nipple. Upon examination it appears to be a small 2mm cyst-like bump -- white, round, mildly painful, a bit itchy. Inside of right breast felt itchy and became rash like red when rubbed/scratched to relieve irritation.  Saturday 10/20 Noon, right nipple still sore and a bit itchy, bump still there, rash from rubbing night before has  subsided some but still there. No recurrence of headache, pain in arm at injection site or sore lymph node on right neck.  Have not consulted with a medical professional but will do so if condition persists on Monday.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old female patient received BNT162b2 (BNT162B2), on 11May2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 61 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results, notes: Both my husband and I took Paxlovid. This is our first case of Covid; (2022) Positive, notes: first positive test; (Jul2022) Negative, notes: day 5; (Jul2022) Negative, notes: day 7; (Jul2022) Positive, notes: day 10. Therapeutic measures were taken as a result of drug ineffective, covid-19. Anti viral details: COVID 19 Treatment with Paxlovid from 06Jul2022 to 11Jul2022.  Adverse event: Both patient husband and she took Paxlovid. This was their first case of Covid. They had both experience Covid rebound. They improved after 5 days of isolation, got sick again on the 10th day after symptoms/first positive test, and have tested positive again. Her husband never tested negative, but she tested negative for Covid by home test on day 5 and 7 after first positive test, and she was feeling very well. Day 9 she started feeling like she was getting a cold, and day 10 she have tested positive again on home test.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Initial symptoms of visual impairment, later diagnosed as visual snow, occurred on Sunday 3/28 along with a headache. Assumed it was a migraine, but after it continued on Monday 3/29 I called advise nurse and scheduled exams for my eyes. The eye doctor confirmed it seems to be experiencing symptoms of visual snow. My vision is currently still looks like static. It has not gone away.  Google search showed potential side effect of astrazeca vaccine in their report so am assuming it is also a side effect of the Johnson and Johnson vaccine as this occurred as a result of receiving it.  I never had this before.
A participant presented at clinic requesting to get a first dose of Pfizer and was registered on site.   After the participant received the Pfizer vaccination, upon review of his appointment in the Database, it was discovered that he had received 9 doses of Pfizer and 1 dose of JNJ at the clinic. A check verified database information and an additional 4 doses of JNJ and 1 Moderna outside of clinic was also identified as well as 2 influenza vaccines. The participant denied receiving multiple doses of vaccine.
discomfort with the first and second shot, a tiny discomfort with the first booster shot; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (discomfort with the first and second shot, a tiny discomfort with the first booster shot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.   On 06-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (discomfort with the first and second shot, a tiny discomfort with the first booster shot). At the time of the report, DISCOMFORT (discomfort with the first and second shot, a tiny discomfort with the first booster shot) outcome was unknown.            Concomitant medication was not reported.  It was reported the patient had a little discomfort with the first and second shot, a tiny discomfort with the first booster shot.  Treatment drug was not reported.   This case was linked to MODERNATX, INC.-MOD-2023-694105 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2023-694105:Bivalent dose
Patient exhibited a seizure like episode that lasted approximately 15 seconds.  Patient was placed on the ground in a supine position where she regained consciousness.  911 was notified at 1401.  Patient with clammy and pale skin.  At 1405 BP was 122/69, HR 100, RR 18.  Attempted to put patient in chair, once in chair she began to feel dizzy and was placed back on the ground in a supine position..  At 1410 BP was 122/58, RR 20.  Blood sugar at 1413 was 92.  Patient was able to sit up on the ground and was given juice and crackers.  Patient continued to have pale and clammy skin.  Alert and oriented x 3.  EMS arrived and patient transported to hospital.
Nauseous, body aches, joint pain, headache, abdominal pain, congestion, ear fullness
Acute pancreatitis; Missed her second shot as she was hospitalized due to Abdominal problem; This spontaneous case was reported by a consumer and describes the occurrence of PANCREATITIS ACUTE (Acute pancreatitis) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced PANCREATITIS ACUTE (Acute pancreatitis) (seriousness criterion hospitalization). On an unknown date, the patient experienced INTENTIONAL DOSE OMISSION (Missed her second shot as she was hospitalized due to Abdominal problem ). The patient was hospitalized from 08-Mar-2021 to 21-Mar-2021 due to PANCREATITIS ACUTE. On 21-Mar-2021, PANCREATITIS ACUTE (Acute pancreatitis) had resolved. At the time of the report, INTENTIONAL DOSE OMISSION (Missed her second shot as she was hospitalized due to Abdominal problem ) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitants were not provided.  Additional information:She missed her second shot as she was hospitalized due to Abdominal problem - acute pancreatitis. She was hospitalized on 8Mar2021 and discharged on 21Mar2021; Sender's Comments: Very limited information has been provided at this time. Further information ahs been requested. Based on the current information and temporal association between the use of the product and the start date of the event a causal relationship cannot be excluded.
and treatment, if any:   Myalgia, Fever. SkinRash & Rash  Narrative:  Fever, body aches, hive rash went PCP, given allergy medication. Rash still present all other symptoms gone at this time.
Pt recv vax on 2/19/99; on 3/1/99 pt exp rash all over-red, raised; fever; sinus infection; tx=Advil
breastfeeding; This spontaneous case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (breastfeeding) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (breastfeeding). At the time of the report, MATERNAL EXPOSURE DURING BREAST FEEDING (breastfeeding) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient is taking antenatal vitamin. No concomitant medications reported by reporter. Treatment medication not reported.
Redness, swelling, tenderness at injection site, with numbness and tingling in the arm, one day after receiving vaccination. Burning in right flank area two days after receiving vaccination.
Patient felt "tickle/scratchiness in throat" 10 minutes after vaccine; BP and pulse stable; no hives, itching, shortness of breath. Took 25 mg of Benadryl and monitored another 15 minutes. VSS; patient felt comfortable leaving; would be in hospital another hour or so,
Patient c/o of arm numbness after receiving vaccine. Numbness lasted for 1 week per patient.  Patient had second dose on 8/22/14 and pt reports he had numbness in entire arm x 1 week again.
Shortly after receiving the injection, I got lightheaded and felt like I might pass out. For several minutes it got gradually worse until about 5-10 minutes when it started to subside. I was told this is likely a nervous reaction, however it doesn't seem like that to me. It felt like I was high on something for a few minutes after I received the injection. I've felt very similar reactions to injections in the past and it's surprisingly similar every time independently of how much I calm myself beforehand. The reaction also isn't immediate, it takes a minute or two to begin. That's why it seems like a physical response vs a nervous response.
1st 24 hours: Rash on her tongue.  Rash gone in four days. 2nd 24 hours: Tongue hurt.  Hot and cold flashes. 4th Day: When moved, tongue, ears uncomfortable (sensitive).  Back begins to be sore and itching spots along her spine.  Spots are like someone is poking her from the inside.  7th Day:  Calves of legs are hurting.  Lymph nodes anterior legs swollen.
first shot December 2020, second shot March 2022; This case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine  (received 1st shot in December 2020).   In March 2022, the patient received the 2nd dose of Shingles vaccine. In March 2022, unknown after receiving Shingles vaccine, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK receipt date: 22-Jul-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient asked question that if his/her 1st shot was in December 2020 and 2nd shot in March 2022, how strong was the effectiveness. The patient also asked that two years was too long in between shots. Additional supportive information: The patient received 2nd dose later than the recommended interval, which led to lengthening of vaccine schedule. The follow-up could not be possible as no contact details were available.
5/4 : Resident with PICC line following course of IV ABX for osteomylitis. Resident was administered Jassen vaccine at 1100am. Resident had PICC line and PIV removed at aprox 1700. He was followed up by nursing staff at 2000 at which time he complained of swelling, redness, and heat to the PICC site.  On-call provider was notified and ordered transportation to Emergency Department for evaluation.  Facility was notified of passing at 0200 on 5/5